BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16713998)

  • 1. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line.
    Tsukahara T; Agawa H; Matsumoto S; Matsuda M; Ueno S; Yamashita Y; Yamada K; Tanaka N; Kojima K; Takeshita T
    Biochem Biophys Res Commun; 2006 Jul; 345(3):1099-107. PubMed ID: 16713998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription start regions in the human genome are favored targets for MLV integration.
    Wu X; Li Y; Crise B; Burgess SM
    Science; 2003 Jun; 300(5626):1749-51. PubMed ID: 12805549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy.
    Bester AC; Schwartz M; Schmidt M; Garrigue A; Hacein-Bey-Abina S; Cavazzana-Calvo M; Ben-Porat N; Von Kalle C; Fischer A; Kerem B
    Gene Ther; 2006 Jul; 13(13):1057-9. PubMed ID: 16511518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.
    Recchia A; Bonini C; Magnani Z; Urbinati F; Sartori D; Muraro S; Tagliafico E; Bondanza A; Stanghellini MT; Bernardi M; Pescarollo A; Ciceri F; Bordignon C; Mavilio F
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1457-62. PubMed ID: 16432223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions.
    Giordano FA; Fehse B; Hotz-Wagenblatt A; Jonnakuty S; del Val C; Appelt JU; Nagy KZ; Kuehlcke K; Naundorf S; Zander AR; Zeller WJ; Ho AD; Fruehauf S; Laufs S
    Bone Marrow Transplant; 2006 Aug; 38(3):229-35. PubMed ID: 16785865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer-deficient amphotropic murine leukemia virus and recombinants with heterologous transcription elements can be efficiently amplified and detected in Mus dunni fibroblasts.
    Reuss FU; Berdel B; Heber R; Ploss M
    Gene Ther; 2002 Sep; 9(17):1183-8. PubMed ID: 12170382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MLV-10A1 retrovirus pseudotype efficiently transduces primary human CD4+ T lymphocytes.
    Gladow M; Becker C; Blankenstein T; Uckert W
    J Gene Med; 2000; 2(6):409-15. PubMed ID: 11199261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted gene transfer to lymphocytes using murine leukaemia virus vectors pseudotyped with spleen necrosis virus envelope proteins.
    Engelstädter M; Buchholz CJ; Bobkova M; Steidl S; Merget-Millitzer H; Willemsen RA; Stitz J; Cichutek K
    Gene Ther; 2001 Aug; 8(15):1202-6. PubMed ID: 11509952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific packaging of spliced retroviral vector transcripts lacking the Psi-region.
    Pambalk K; Hohenadl C; Salmons B; Günzburg WH; Renner M
    Biochem Biophys Res Commun; 2002 Apr; 293(1):239-46. PubMed ID: 12054590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suspension packaging cell lines for the simplified generation of T-cell receptor encoding retrovirus vector particles.
    Reuss S; Biese P; Cosset FL; Takeuchi Y; Uckert W
    Gene Ther; 2007 Apr; 14(7):595-603. PubMed ID: 17235289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amphotropic murine leukemia virus replication in human mammary epithelial cells and the formation of cytomegalovirus-promoter recombinants.
    Reuss FU; Heber R; Ploss A; Berdel B
    Virology; 2001 Dec; 291(1):91-100. PubMed ID: 11878879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The perforin-dependent immunological synapse allows T-cell activation-dependent tumor targeting by MLV vector particles.
    Kottke T; Qiao J; Diaz RM; Ahmed A; Vroman B; Thompson J; Sanchez-Perez L; Vile R
    Gene Ther; 2006 Aug; 13(15):1166-77. PubMed ID: 16625245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation.
    Meier-Noorden M; Flindt S; Kalinke U; Hinz T
    Gene; 2004 Sep; 338(2):197-207. PubMed ID: 15315823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells.
    Beard BC; Dickerson D; Beebe K; Gooch C; Fletcher J; Okbinoglu T; Miller DG; Jacobs MA; Kaul R; Kiem HP; Trobridge GD
    Mol Ther; 2007 Jul; 15(7):1356-65. PubMed ID: 17440443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retroviral DNA integration: viral and cellular determinants of target-site selection.
    Lewinski MK; Yamashita M; Emerman M; Ciuffi A; Marshall H; Crawford G; Collins F; Shinn P; Leipzig J; Hannenhalli S; Berry CC; Ecker JR; Bushman FD
    PLoS Pathog; 2006 Jun; 2(6):e60. PubMed ID: 16789841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral vector integration sites in human NOD/SCID repopulating cells.
    Laufs S; Guenechea G; Gonzalez-Murillo A; Zsuzsanna Nagy K; Luz Lozano M; del Val C; Jonnakuty S; Hotz-Wagenblatt A; Jens Zeller W; Bueren JA; Fruehauf S
    J Gene Med; 2006 Oct; 8(10):1197-207. PubMed ID: 16960916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene transfer of human TCR in primary murine T cells is improved by pseudo-typing with amphotropic and ecotropic envelopes.
    Pouw NM; Westerlaken EJ; Willemsen RA; Debets R
    J Gene Med; 2007 Jul; 9(7):561-70. PubMed ID: 17471588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene encoding thioredoxin-interacting protein (TXNIP) is a frequent virus integration site in virus-induced mouse leukemia and is overexpressed in a subset of AML patients.
    Erkeland SJ; Palande KK; Valkhof M; Gits J; Danen-van Oorschot A; Touw IP
    Leuk Res; 2009 Oct; 33(10):1367-71. PubMed ID: 19327827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors.
    Pizzato M; Merten OW; Blair ED; Takeuchi Y
    Gene Ther; 2001 May; 8(10):737-45. PubMed ID: 11420637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.